Riddhi Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-12-2024
- Paid Up Capital ₹ 0.50 M
as on 05-12-2024
- Company Age 21 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.75 Cr
as on 05-12-2024
- Satisfied Charges ₹ 2.99 Cr
as on 05-12-2024
- Revenue -88.13%
(FY 2022)
- Profit 508.44%
(FY 2022)
- Ebitda -92.59%
(FY 2022)
- Net Worth 16.07%
(FY 2022)
- Total Assets -5.32%
(FY 2022)
About Riddhi Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹8.75 Cr. The company has closed loans amounting to ₹2.99 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rekha Ahuja and Rajesh Ahuja serve as directors at the Company.
- CIN/LLPIN
U51101GJ2003PTC041902
- Company No.
041902
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2003
- Date of AGM
24 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationVadodara, Gujarat
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Riddhi Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rekha Ahuja  | Director | 27-Jan-2003 | Current |
| Rajesh Ahuja | Director | 27-Jan-2003 | Current |
Financial Performance and Corporate Structure Insights of Riddhi Remedies.
Riddhi Remedies Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 88.13% decrease. The company also saw a substantial improvement in profitability, with a 508.44% increase in profit. The company's net worth Soared by an impressive increase of 16.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Riddhi Remedies?
In 2021, Riddhi Remedies had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Oct 2021 | ₹8.75 Cr | Open |
Others Creation Date: 02 Nov 2021 | ₹4.69 M | Satisfied |
Union Bank Of India Creation Date: 30 Sep 2011 | ₹1.27 Cr | Satisfied |
How Many Employees Work at Riddhi Remedies?
Unlock and access historical data on people associated with Riddhi Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Riddhi Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Riddhi Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
